Since working in a medical facility and seeing the techniques used by pharmaceutical manufacturers to market their products, I've become curious enough to attempt to follow pro-corporate legislation - and discourage any legislation that may limit profits - in this huge, for-profit industry. Under the guise of "education", physicians are treated to cruises, trips to places I'd certainly like to go, and other benefits. ALEC, according to their own documents, wants to eliminate any attempt to regulate these marketing techniques to keep prices down (!?!?).
To quote ALEC, in this document:
Director, Health and Human Services Task Force
American Legislative Exchange Council
Texas Senate Health and Human Services Committee
April 30, 2009they opposed legislation:
"..which would require pharmaceutical and medical device manufacturers to disclose "payments or transfers of value" to associated health care entities."
The following quotes are liberated :-) from sites which encourage investment in the pharmaceutical industry. The potential profits for those willing to invest are extraordinary. I leave you to judge the morality behind ALEC's motivations for (given that many of their influential/high-paying members are the huge pharmaceutical manufacturers) and the politicians who (again, receiving huge donations from the same manufacturers) engage in fighting against any legislation intended to control the marketing practices of these ALEC members.
To me, it's clearly immoral.
... there are still great benefits to be reaped however. In the end, how can you beat a business that makes a pill for a few pennies and sells for a few dollars? The economics are just too good to avoid!
Hmmm. Try removing "the growing demand for drugs and medication for" from this quote:
One has to admit that the pharmaceutical industry has a very good position to take great advantage of the growing demand for drugs and medication for the sick and elderly.
This "investment opportunity" document (source below in this section) contains much about the methodology and benefits of building "positive behaviors of loyal physicians" - sales techniques designed to increase prescriptions written for branded medications, and to encourage physician-to-physican marketing.
For this company, the payoff was $14 million per year in GI and $20 million per year in respiratory.And it is important to note that these are conservative estimates: They only include the direct impact of loyalty on sales, not any of the increased sales and profits that result from other positive behaviors of loyal physicians.